Internal Medicine Doctors in Social Circle, GA Accepting Medicare
5 Internal Medicine doctors found. Showing 1 - 5
 Henry M Patton, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 551 N Cherokee Rd, Social Circle, GA 30025 Phone: 678-342-6000 |
Dr. Kwon S Choe, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 551 N Cherokee Rd, Social Circle, GA 30025 Phone: 770-787-6900 Fax: 770-787-6962 |
George Timothy Park, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 551 N Cherokee Rd, Social Circle, GA 30025 Phone: 678-342-6000 |
 Dr. Belinda Doreen Chambers, NP Internal Medicine Medicare: Medicare Enrolled Practice Location: 551 N Cherokee Rd, Social Circle, GA 30025 Phone: 678-342-6000 |
Kevin D Lanclos, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 551 N Cherokee Rd, Social Circle, GA 30025 Phone: 770-787-6900 Fax: 770-787-6962 |
News Archive
Document Storage Systems bags claims processing contract from Department of Veteran Affairs
The Department of Veteran Affairs (VA) has awarded the Purchased Care Health Care Claims Processing solicitation to Document Storage Systems, Inc. (DSS). The Veterans Administration, where medical appropriateness and/or distance from care are an issue, contracts medical services for our nation's Veterans.
Aptus Endosystems announces completion of $15M Series AA financing
Aptus Endosystems, Inc., a medical device company developing advanced technology for endovascular aneurysm repair, announced the completion of a $15 million Series AA financing. U.S. Venture Partners and Longitude Capital led the round in continuation of their commitment to Aptus' innovative technologies for the treatment of aortic aneurysms.
Study shows positive impacts of replacing old furniture containing flame retardants
A new study shows that when people replace their old couch with a new one that has no added flame retardants, levels of the harmful chemicals in household dust drop significantly.
CHMP recommends approval of Otsuka's Deltyba for pulmonary multidrug-resistant tuberculosis
Otsuka Pharmaceutical Co., Ltd. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval of Deltyba (delamanid) in combination with a WHO recommended optimized background regimen for the treatment of pulmonary multidrug-resistant tuberculosis (MDR-TB). The CHMP opinion will help form the basis for a European Commission decision expected early next year.
› Verified 5 days ago